A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Journal: Nature Communications

Published: 2020-02-05

DOI: 10.1038/s41467-019-13825-8

Affiliations: 69

Authors: 61

Go to article
Institutions Share
Ontario Institute for Cancer Research (OICR), Canada 0.12
Massachusetts General Hospital (MGH), United States of America (USA) 0.12
University of Glasgow, United Kingdom (UK) 0.06
Genome Informatics Program, OICR, Canada 0.06
University of Toronto (U of T), Canada 0.05
University Medical Center Utrecht (UMC Utrecht), Netherlands 0.04
Broad Institute of MIT and Harvard, United States of America (USA) 0.04
MRC Institute of Genetics and Molecular Medicine (IGMM), United Kingdom (UK) 0.03
University of Zagreb, Croatia 0.03
Oregon Health and Science University (OHSU), United States of America (USA) 0.03
National Cancer Center (NCC), Japan 0.02
Cornell University, United States of America (USA) 0.02
Wellcome Trust Genome Campus, United Kingdom (UK) 0.02
Harvard University, United States of America (USA) 0.02
The University of Melbourne (UniMelb), Australia 0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.02
Sage Bionetworks, United States of America (USA) 0.02
University of Cambridge, United Kingdom (UK) 0.02
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.02
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.02
Spanish National Cancer Research Centre (CNIO), Spain 0.02
Radboud University Medical Centre (Radboudumc), RU, Netherlands 0.02
Netherlands Cancer Institute (NKI), Netherlands 0.02
Erasmus University Medical Center (Erasmus MC), Netherlands 0.02
Vector Institute, Canada 0.01
University of New South Wales (UNSW Sydney), Australia 0.01
The Kinghorn Cancer Centre (TKCC), Australia 0.01
CRUK Beatson Institute for Cancer Research, United Kingdom (UK) 0.01
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.01
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.01
The University of Tokyo (UTokyo), Japan 0.01
MRC-University of Glasgow Centre for Virus Research (CVR), United Kingdom (UK) 0.01
Pompeu Fabra University (UPF), Spain 0.01
National Centre for Genomic Analysis (CNAG), CRG BIST, Spain 0.01
Ulm University Medical Center, Germany 0.01
UCSF Medical Center, United States of America (USA) 0.01
University Medical Center Schleswig-Holstein - Campus Kiel (UKSH Kiel), Germany 0.01
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.01
University of Bern (UniBE), Switzerland 0.01
Hartwig Medical Foundation, Netherlands 0.01
Oncode Institute, Netherlands 0.01
MRC Cancer Unit, University of Cambridge, United Kingdom (UK) 0
University of California, Los Angeles (UCLA), United States of America (USA) 0
Glasgow Royal Infirmary (GRI), United Kingdom (UK) 0
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0
Bern University Hospital, Switzerland 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER